A gene signature identifying CIN3 regression and cervical cancer survival

Autor: Emiel A. M. Janssen, Ingfrid S. Haldorsen, Bjørn I. Bertelsen, Saleha Akbari, Einar Gudslaugsson, Ane Cecilie Munk, Mari K. Halle, Camilla Krakstad, David Forsse, Kathrine Woie, Erling A. Hoivik, Birgit Engesæter, Irene T Øvestad, Kristine Eldevik Fasmer, Astri Frafjord
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Cancers
Cancers, Vol 13, Iss 5737, p 5737 (2021)
Volume 13
Issue 22
Popis: The purpose of this study was to establish a gene signature that may predict CIN3 regression and that may aid in selecting patients who may safely refrain from conization. Oncomine mRNA data including 398 immune-related genes from 21 lesions with confirmed regression and 28 with persistent CIN3 were compared. L1000 mRNA data from a cervical cancer cohort was available for validation (n = 239). Transcriptomic analyses identified TDO2 (p = 0.004), CCL5 (p <
0.001), CCL3 (p = 0.04), CD38 (p = 0.02), and PRF1 (p = 0.005) as upregulated, and LCK downregulated (p = 0.01) in CIN3 regression as compared to persistent CIN3 lesions. From these, a gene signature predicting CIN3 regression with a sensitivity of 91% (AUC = 0.85) was established. Transcriptomic analyses revealed proliferation as significantly linked to persistent CIN3. Within the cancer cohort, high regression signature score associated with immune activation by Gene Set enrichment Analyses (GSEA) and immune cell infiltration by histopathological evaluation (p <
0.001). Low signature score was associated with poor survival (p = 0.007) and large tumors (p = 0.01). In conclusion, the proposed six-gene signature predicts CIN regression and favorable cervical cancer prognosis and points to common drivers in precursors and cervical cancer lesions.
Databáze: OpenAIRE